Tag: Advances in Care

Kids, Young Adults, News, Research, Living with Muscular Dystrophy

Researchers Announce Results from a Phase 3 Study of Corticosteroid Dosing to Treat DMD

Sujatha Gurunathan

On April 5, an international research team, headed by Michela Guglieri at Newcastle University and Robert Griggs at the University of Rochester Medical Center, announced positive results at the American Academy of Neurology (AAN meeting) in Seattle, WA from the phase 3 FOR DMD study of corticosteroid dosing regimens for treatment of people with Duchenne . . .

Read More
Adults, Research, Living with Muscular Dystrophy

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG

MDA Staff

Researchers at Alexion Pharmaceuticals are seeking adults living with generalized myasthenia gravis (gMG) to participate in a phase 2 clinical trial to evaluate the safety, effectiveness, and pharmacological properties of the investigational drug ALXN2050. ALXN2050 is designed to target a component of the immune system (known as complement), which underlies many autoimmune disorders including gMG. People . . .

Read More